This episode currently has no reviews.
Submit ReviewIt’s the busiest week of earnings season, combined with a ton of macro data and Wednesday’s Fed decision on interest rates. We’ll look at how to position for this massive market-moving week. Plus, Vanguard has a new CEO and it’s the first-ever outsider to helm the company. Bob Pisani sits down with him four weeks into the job. And we’ll bring you the action, the story, and the trade on Procter & Gamble, JetBlue, and Pfizer.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review